All resources
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Podcast Episode
11: Implementing Adaptive Trials
In Episode 11 of "In the Interim...", host Scott Berry discusses the nuances of implementing adaptive clinical trials with Dr. Anna McGlothlin and Dr. Michelle Detry from Berry Consultants.
Blog
Revisiting a Seamless 2/3 Trial: The Amazing Journey of a GLP-1 Agonist
Explore the intricacies of the AWARD-5 trial for Eli Lilly's dulaglutide, from complex trial design to the transformation of pharmaceutical development timelines.
Podcast Episode
10: Revisiting Seamless 2/3 Trial for GLP-1 Agonist
In this episode of "In the Interim..." we revisit the ground-breaking seamless phase 2/3 clinical trial for the GLP-1 agonist, dulaglutide—better known as Trulicity.
News and Events
Episode 10, “Revisiting Seamless 2/3 Trial for GLP-1 Agonist"
In this episode of "In the Interim..." we revisit the ground-breaking seamless phase 2/3 clinical trial for the GLP-1 agonist, dulaglutide—better known as Trulicity.
Blog
The Role of Innovative Trial Designs in Transforming Clinical Research
Explore how adaptive platform trials like I-SPY2 and GBM AGILE are revolutionizing clinical research to accelerate drug development.
Blog
Longitudinal Modeling in Clinical Trial Design: Methodological Advantages & Challenges
Longitudinal models can improve the efficiency in clinical trial decision making. So are we taking full advantage of this opportunity? This blog discusses methodological advantages and challenges.
No results found.
There are no results with this criteria. Try changing your search.
